CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research

LONDON, May 25, 2026 /PRNewswire/ -- The global CGRP inhibitors market is expanding rapidly, expected to be valued at around US$ 6.5 billion in 2026 and projected to reach US$ 12.5 billion by 2033, with a CAGR of 9.7% in the coming years. This growth is driven by the rising prevalence of...